Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,588.00    22.00 (0.48%)
Bid:
4,586.00
Ask:
4,590.00
Spread: 4.00 (0.087%)
Market Cap: £16.72b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Final Terms - 2032 Notes

19 Nov 2024 11:14

RNS Number : 8180M
Coca-Cola HBC AG
19 November 2024
 

Coca-Cola HBC Finance B.V.

(a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

(a company incorporated with limited liability in Switzerland)

 

Zug, Switzerland and Amsterdam, The Netherlands 19 November 2024 - The following Final Terms are available for viewing:

· Final Terms dated 18 November 2024 in respect of the EUR 500,000,000 3.125 per cent. Notes due 20 November 2032;

to be issued by Coca-Cola HBC Finance B.V. under its €5,000,000,000 Euro Medium Term Note Programme, and guaranteed by Coca-Cola HBC AG.

This announcement must be read in conjunction with the Base Prospectus dated 19 December 2023, as supplemented by two supplements dated 15 February 2024 and 12 November 2024 (the "Base Prospectus") which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

To view the Final Terms and the Base Prospectus, please paste the following URL into the address bar of your browser:

 

https://www.coca-colahellenic.com/en/investor-relations/debt-investors

 

The Final Terms have also been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Disclaimer

The Base Prospectus and/or the Final Terms do not constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

Please note that the information contained in the Final Terms and/or the Base Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and/or the Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and/or the Base Prospectus you must ascertain from the Final Terms and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

 

Joanna Kennedy

Head of Investor Relations

Tel: +44 7802 427505

 joanna.kennedy@cchellenic.com

 

Jemima Benstead

Senior Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

 

Virginia Phillips

Investor Relations Manager

Konstantina Galani

Investor Relations Manager

Tel: +44 7864 686582

virginia.phillips@cchellenic.com

Tel: +30 6973232802

konstantina-styliani.galani@cchellenic.com

 

Media: 

Sonia Bastian 

Head of Communications 

Tel: +41 7946 88054 

sonia.bastian@cchellenic.com 

Claire Evans

Group Senior Communications Manager - Corporate

 

Tel:+44 7597 562 978 

claire.evans@cchellenic.com

 About Coca-Cola HBC

 

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC is listed on the London Stock Exchange (LSE: CCH) and on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTUKAARSRUAAAA
Date   Source Headline
19th Nov 20203:44 pmRNSPublication of Suppl.Prospcts
18th Nov 20202:23 pmRNSDirector/PDMR Shareholding
11th Nov 20207:00 amRNSSTRONGLY IMPROVED TRADING IN Q3
2nd Nov 20209:07 amRNSIssue of equity and total voting rights
21st Oct 20205:00 pmRNSAppointment of Chief Financial Officer
19th Oct 20202:26 pmRNSDirector/PDMR Shareholding
12th Oct 202012:44 pmRNSNotice of Results
25th Sep 202010:09 amRNSDirector Declaration
18th Sep 20201:31 pmRNSDirector/PDMR Shareholding
9th Sep 20204:24 pmRNSPublication of Suppl.Prospcts
1st Sep 202010:31 amRNSIssue of equity and total voting rights
18th Aug 202012:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:08 pmRNSDirector Declaration
7th Aug 202010:54 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSENCOURAGING SIGNS AS MARKETS REOPEN
4th Aug 20203:05 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:01 amRNSTotal Voting Rights
31st Jul 20202:46 pmRNSNotice of Results-New time for the analysts call
20th Jul 20203:19 pmRNSDirector/PDMR Shareholding
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding
25th Jun 20203:38 pmRNSDirector/PDMR Shareholding
18th Jun 20202:35 pmRNSDirector/PDMR Shareholding
18th Jun 20207:42 amRNSCFO to step down in the first quarter of 2021
16th Jun 20203:54 pmRNSDirector/PDMR Shareholding
16th Jun 20201:42 pmRNSComposition of the Committees of the BoD
16th Jun 20201:06 pmRNSResult of AGM
12th Jun 20201:59 pmRNSAthens Exchange trading date of ordinary shares
9th Jun 20209:40 amRNSDirector/PDMR Shareholding
19th May 20201:08 pmRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSAGM notice, changes to the BoD and dividend dates
11th May 20205:39 pmRNSPublication of Suppl.Prospcts
7th May 20207:00 amRNSKEEPING OUR PEOPLE SAFE AND CUSTOMERS SERVED
1st May 202010:36 amRNSBlock listing Interim Review
30th Apr 20204:13 pmRNSDirector/PDMR Shareholding
30th Apr 20203:59 pmRNSPublication of a Prospectus
27th Apr 20205:42 pmRNSDisclosure of Rights attached to Equity Shares
21st Apr 20201:00 pmRNSDirector/PDMR Shareholding
14th Apr 20203:33 pmRNSNotice of Results
9th Apr 20205:45 pmRNSTotal Voting Rights - Replacement
9th Apr 20205:18 pmRNSTotal Voting Rights
27th Mar 20201:10 pmRNSDirector/PDMR Shareholding
27th Mar 20207:00 amRNSCovid-19 update and actions
19th Mar 20203:39 pmRNSDirector/PDMR Shareholding
19th Mar 20203:01 pmRNSDirector/PDMR Shareholding
19th Mar 202011:16 amRNSWhat it takes to deliver 24/7
18th Mar 20201:36 pmRNSDirector/PDMR Shareholding
2nd Mar 20201:39 pmRNSissue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.